Cardiac failure in patients with valvar heart disease after use of propranolol to control atrial fibrillation.
D000328:Adult; D001021:Aortic Valve; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006339:Heart Rate; D006349:Heart Valve Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000150:complications; D011433:Propranolol / Q000009:adverse effects*; D012214:Rheumatic Heart Disease / Q000150:complications; D013565:Sympatholytics
D013565:Sympatholytics; D004077:Digoxin; D011433:Propranolol